AMGEN INC — Director's Dealing 2024

Dec 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2024-12-05

Reporting Person: Graham Jonathan P (EVP & Gen. Counsel & Secy.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-05	Common Stock	G	6430	—	Disposed	28903	Direct

Footnotes

F1: These shares were gifted by the reporting person and the reporting person's spouse to two irrevocable trusts for the benefit of the reporting person's adult children. Neither the reporting person nor the reporting person's spouse are trustees of the trusts or otherwise have the power to vote or dispose of the assets held in such trusts.

F2: Shares directly beneficially owned also include 550 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested restricted stock units (RSUs) and are paid out in shares of the Company's common stock on a one-to-one basis upon vesting of the associated RSUs with a cash payment for any remaining fractional share amount.